Clinical Trials on Sudden Cardiac Arrest in Japan

Total 136 results

Boston Scientific Corporation
ICON Clinical Research

Completed

Heart Failure and Sudden Cardiac Death Japan Registry (HINODE)

Heart Failure | Arrhythmias, Cardiac | Sudden Cardiac Death

Japan
University of Arizona

Completed

Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD)

Ventricular Tachycardia (VT)

Japan, Taiwan, China, United States, Korea, Republic of
Boston Scientific Corporation

Completed

Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)

Sudden Cardiac Death

United States, Spain, Korea, Republic of, United Kingdom, Canada, Japan, Austria, Italy
Kobe University
Mochida Pharmaceutical Company, Ltd.

Completed

Protective Effect of EPA on Cardiovascular Events

Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease

Japan
ZOLL Circulation, Inc., USA
Asahi Kasei Medical Co., Ltd.

Completed

Therapeutic Hypothermia With IntraVascular Temperature Management (IVTM) in Post-Cardiogenic Cardiac Arrest and Post-Return of Spontaneous Circulation Patients in Japan

Cardiac Arrest

Japan
National Cerebral and Cardiovascular Center

Completed

Multicenter Registry Study With Therapeutic Hypothermia After Cardiac Arrest in Japan (J-PULSE-HYPO)

Cardiac Arrest

Japan
Children's Hospital of Philadelphia
Zoll Medical Corporation

Recruiting

Quality of Pediatric Resuscitation in a Multicenter Collaborative (pediRES-Q)

Cardiac Arrest | Cardiopulmonary Arrest

United States, Australia, Singapore, Canada, United Kingdom, Taiwan, Colombia, Japan
Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Cardiac Edema (CHF)

Japan
National Cerebral and Cardiovascular Center

Recruiting

Japanese Lead Extraction Registry (J-LEX)

Arrhythmia, Cardiac

Japan
National Cerebral and Cardiovascular Center

Recruiting

Japanese Catheter Ablation Registry (J-AB)

Cardiac Arrhythmias | Catheter Ablation

Japan
Yokohama City University Medical Center
Novartis Pharmaceuticals

Unknown

Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept

The Injection Burden

Japan
Toujinkai Hospital

Completed

Circulating P3NP and Cardiovascular Events in Hemodialysis Patients

Cardiac Fibrosis | Cardiovascular Events

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

Cardiac Edema

Japan
Bayer
Regeneron Pharmaceuticals

Completed

Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan

Wet Macular Degeneration

Japan
Boehringer Ingelheim

Completed

Japanese Pradaxa PMS, Long Term

Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

Atrial Fibrillation

Japan
Daiichi Sankyo Co., Ltd.

Completed

Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation

Atrial Fibrillation

Japan
Kyoto University, Graduate School of Medicine

Completed

Kansai Plus Atrial Fibrillation Trial (KPAF)

Atrial Fibrillation

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)

Atrial Fibrillation

Japan
Japan Cardiovascular Research Foundation

Unknown

GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence (GENeRAL)

Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Treatment Pattern of Oral Anticoagulants (OAC) in Japan

Atrial Fibrillation

Japan
Nagoya University

Unknown

Investigation of Genetic Risk of Atrial Fibrillation

Atrial Fibrillation

Japan
Biotronik Japan, Inc.

Completed

Safety and Efficacy Study of IPG Patient With Home Monitoring

Bradyarrhythmia

Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Non-valvular Atrial Fibrillation

Japan
Pfizer

Completed

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation (CER3)

Non-valvular Atrial Fibrillation

Japan
Bristol-Myers Squibb

Completed

A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Non-Valvular Atrial Fibrillation (NVAF)

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males

Arrhythmia

Japan
Boehringer Ingelheim

Completed

Medical Need of OAC Reversal

Atrial Fibrillation

Japan
Bristol-Myers Squibb
Pfizer

Completed

Evaluation of Safety and Effectiveness on Oral Anticoagulants (RCR-OAC)

Atrial Fibrillation

Japan
Bristol-Myers Squibb

Completed

Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection Rate

Atrial Fibrillation

Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data

Non-valvular Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Atrial Fibrillation

Japan
Pfizer

Completed

Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

Non-valvular Atrial Fibrillation

Japan
Kumamoto University

Completed

Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT

Coronary Artery Disease | Cardiac CT

Japan
Bayer
Janssen Scientific Affairs, LLC

Completed

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Non-valvular Atrial Fibrillation (NVAF)

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)

Cardiac Edema

Japan
Bristol-Myers Squibb
Pfizer

Completed

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

NonValvular Atrial Fibrillation

Japan
Ministry of Health, Labour and Welfare, Japan

Completed

Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery

Coronary Disease | Atrial Fibrillation

Japan
Nara Medical University

Unknown

Hemofiltration for Contrast-Induced Nephropathy

Chronic Kidney Disease | Cardiac Catheterization

Japan
Satoshi Shizuta
Daiichi Sankyo Co., Ltd.; Research Institute for Production Development

Completed

Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study (OAC-ALONE)

Coronary Artery Disease | Atrial Fibrillation

Japan
Institute for Clinical Effectiveness, Japan

Recruiting

Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial (LEAP-AF)

Persistent Atrial Fibrillation | Catheter Ablation | Pulmonary Vein Isolation | Posterior Wall Isolation

Japan
Bayer

Completed

Bioequivalence Study of Rivaroxaban

Embolism, Atrial Fibrillation and Venous Thrombosis

Japan
Bayer

Completed

Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects

Embolism, Atrial Fibrillation and Venous Thrombosis

Japan
Japan Cardiovascular Research Foundation

Unknown

Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study (AFIRE)

Atrial Fibrillation

Japan
Biotronik Japan, Inc.

Completed

Monitoring of Fluid Status in Heart Failure Patients by Intrathoracic Impedance Measurement in Japan (J-HomeCARE II)

Heart Failure | Arrhythmias, Cardiac

Japan
Novo Nordisk A/S

Completed

Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers

Healthy | Acquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary Bypass

Japan
Toujinkai Hospital

Completed

Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients

Congestive Heart Failure | Acute Myocardial Infarction

Japan
Tohoku University

Unknown

Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation (EXPAND)

Non-valvular Atrial Fibrillation

Japan
Daiichi Sankyo Co., Ltd.

Completed

Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment

Non-valvular Atrial Fibrillation

Japan
Acrobat Trial Group

Unknown

ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT) (ACROBAT)

Hypertension and Atrial Fibrillation

Japan

3

Subscribe